• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$38.61 -$0.08 (-0.21%)

REAL-TIME: Last trade at

Teva Pharmaceutical Industries

NASDAQ:TEVA

Jump to this page for:

Related Resources

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 5

5/28/2012 by Seeking Alpha

Is Teva Pharmaceuticals An 'Investment Classic'?

5/26/2012 by Seeking Alpha

5 Fears For Friday's Market

5/25/2012 by Seeking Alpha

Abbott Wants To Extract More From Humira While Pfizer Slogs Along With Lipitor

5/25/2012 by Trefis

Teva Pharmaceuticals: The Bottom Is Finally In For These Beaten Down Shares

5/24/2012 by Seeking Alpha

Johnson & Johnson Setback Is Positive for Pfizer, Bristol-Myers

5/24/2012 by Minyanville

Teva Pharma Reduces 2012 Guidance On Lower Generics View

5/24/2012 by Smart Money

This Just In: Upgrades and Downgrades

5/24/2012 by DailyFinance

4 Interesting Top-Growth Stocks By Richard Snow

5/24/2012 by Seeking Alpha

7 Health-Care Dividend Stocks With Encouraging Accounts Receivable Trends

5/24/2012 by DailyFinance

Buy, Sell, or Hold: Johnson & Johnson

5/23/2012 by DailyFinance

Pharma Updates: Pfizer Recalls Advil & Merck’s Propecia Causes Furor

5/23/2012 by Trefis

Bob McDonald’s Quandary: Save the World or Maintain P&G’s Dividend, Yielding 3.5%

5/23/2012 by YCharts

Has Momenta Pharmaceuticals Become the Perfect Stock?

5/22/2012 by DailyFinance

Dr. Reddy's Launches Plavix' Generic - Analyst Blog

5/18/2012 by Nasdaq

FDA Approves Generic Versions Of Blood Thinning Drug Plavix

5/17/2012 by Smart Money

UPDATE:FDA Approves Generic Versions Of Blood-Thinning Drug Plavix

5/17/2012 by Smart Money

How High Can Biogen Idec Fly?

5/16/2012 by DailyFinance

Your Warning Label Is My Sales Brochure

5/16/2012 by DailyFinance

Abbott Stands Up to Obamacare

5/16/2012 by DailyFinance

5 CEOs to Start Watching Now

5/15/2012 by DailyFinance

Johnson & Johnson’s CEO Looks To Bolster Cardiology Devices Segment Through Acquisitions

5/15/2012 by Trefis

Johnson & Johnson’s CEO Looks To Bolster Cardiology Devices Segment Through Acquisitions

5/15/2012 by Trefis

Drug Approval! Oh, Wait, We Knew That Already.

5/12/2012 by DailyFinance

Abbott Settles Depakote Suit For $1.5 billion; Urges FDA To Block Generics

5/11/2012 by Trefis

Abbott Settles Depakote Suit For $1.5 billion; Urges FDA To Block Generics

5/11/2012 by Trefis

This Just In: Upgrades and Downgrades

5/11/2012 by DailyFinance

Pfizer To Invest $3 Billion In Indonesia; Lost Opportunity In Tofacitinib

5/10/2012 by Trefis

Top Analyst Upgrades & Downgrades (ARMH, BIG, CHKM, CSCO, CPWM, DLB, HGSI, JDSU, LINE, MMM, NOV, ORC

5/10/2012 by 247wallst

Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter

5/10/2012 by Nasdaq

24/7 Wall St. Closing Bell (ORCL, NOV, MMM, TEVA, JDSU, AMCX, MT, HNR, KSS, WIN, DDS, JKS, PGR, SOL,

5/10/2012 by 247wallst

Updates, advisories and surprises

5/9/2012 by MarketWatch

Teva Profit Surges In First Quarter On Branded, Generic Drug Sales

5/9/2012 by Smart Money

Stocks to watch Wednesday: Tyco, Westport

5/9/2012 by MarketWatch

How Abbott Labs Can Gain at Pfizer’s Expense

5/9/2012 by Trefis

Teva Pharmaceutical Industries Beats Analyst Estimates on EPS

5/9/2012 by DailyFinance

UPDATE: Teva 1Q Profit Up 13% On Branded, Generic Drug Sales

5/9/2012 by Smart Money

Has InterMune Become the Perfect Stock?

5/7/2012 by DailyFinance

Tysabri's Looking Good at a Crossroads

5/4/2012 by DailyFinance

Myriad Beats, Raises Guidance - Analyst Blog

5/2/2012 by Nasdaq
See More Articles...